Unknown

Dataset Information

0

IGF1R as a Potential Pharmacological Target in Allergic Asthma.


ABSTRACT:

Background

Asthma is a chronic lung disease characterized by reversible airflow obstruction, airway hyperresponsiveness (AHR), mucus overproduction and inflammation. Although Insulin-like growth factor 1 receptor (IGF1R) was found to be involved in asthma, its pharmacological inhibition has not previously been investigated in this pathology. We aimed to determine if therapeutic targeting of IGF1R ameliorates allergic airway inflammation in a murine model of asthma.

Methods

C57BL/6J mice were challenged by house dust mite (HDM) extract or PBS for four weeks and therapeutically treated with the IGF1R tyrosine kinase inhibitor (TKI) NVP-ADW742 (NVP) once allergic phenotype was established.

Results

Lungs of HDM-challenged mice exhibited a significant increase in phospho-IGF1R levels, incremented AHR, airway remodeling, eosinophilia and allergic inflammation, as well as altered pulmonary surfactant expression, all of being these parameters counteracted by NVP treatment. HDM-challenged lungs also displayed augmented expression of the IGF1R signaling mediator p-ERK1/2, which was greatly reduced upon treatment with NVP.

Conclusions

Our results demonstrate that IGF1R could be considered a potential pharmacological target in murine HDM-induced asthma and a candidate biomarker in allergic asthma.

SUBMITTER: Alfaro-Arnedo E 

PROVIDER: S-EPMC8389607 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5085797 | biostudies-other
| S-EPMC7895314 | biostudies-literature
| S-EPMC6627083 | biostudies-other
| S-EPMC3672007 | biostudies-literature
| S-EPMC4973311 | biostudies-literature
| S-EPMC4450655 | biostudies-literature
| S-EPMC6954552 | biostudies-literature
| S-EPMC6962376 | biostudies-literature
2023-06-02 | PXD029715 | Pride
2022-06-09 | PXD033172 | Pride